Accession | Mol. Wt. (Da) | pI | II | AI | GRAVY | −R | +R |
---|---|---|---|---|---|---|---|
ACA61132.1 | 62309.11 | 6.69 | 26.05 | 71.30 | −0.538 | 66 | 65 |
ACA61135.1 | 61703.39 | 5.80 | 22.41 | 70.40 | −0.497 | 66 | 60 |
ACA61137.1 | 60675.41 | 8.55 | 28.92 | 75.59 | −0.415 | 56 | 60 |
ACA61140.1 | 60318.78 | 5.20 | 22.82 | 72.46 | −0.467 | 70 | 53 |
ACA61144.1 | 56867.11 | 5.52 | 30.56 | 74.12 | −0.353 | 61 | 51 |
ACA61145.1 | 58714.68 | 5.50 | 36.24 | 67.59 | −0.451 | 60 | 49 |
ACA61149.1 | 57251.13 | 4.97 | 26.20 | 71.13 | −0.312 | 67 | 48 |
ACA61152.1 | 39812.18 | 4.79 | 38.04 | 69.68 | −0.273 | 46 | 29 |
ACA61160.1 | 56643.65 | 5.00 | 33.62 | 77.97 | −0.233 | 68 | 49 |
ACA61162.1 | 38377.09 | 4.99 | 40.12 | 74.97 | −0.401 | 53 | 36 |
ACA61171.1 | 45519.42 | 5.15 | 46.34 | 80.91 | −0.549 | 60 | 43 |
ACH67609.1 | 39813.14 | 5.91 | 42.66 | 80.90 | −0.344 | 44 | 36 |
ADB80100.1 | 59396.57 | 5.56 | 33.30 | 62.20 | −0.498 | 60 | 49 |
ADB80110.1 | 39072.39 | 4.91 | 38.73 | 75.34 | −0.239 | 46 | 29 |
ADB80112.1 | 43461.81 | 4.99 | 39.17 | 75.14 | −0.562 | 60 | 38 |
ADK55024.1 | 62292.29 | 5.39 | 26.55 | 74.01 | −0.501 | 71 | 60 |
ADR64667.1 | 64828.05 | 6.01 | 34.79 | 72.45 | −0.329 | 74 | 65 |
ADR64668.1 | 79700.04 | 4.85 | 23.17 | 74.18 | −0.372 | 91 | 61 |
AEX97595.1 | 83414.86 | 4.91 | 29.01 | 68.77 | −0.480 | 91 | 65 |
AEX97596.1 | 51859.43 | 4.47 | 27.19 | 75.05 | −0.207 | 56 | 29 |
AFQ39736.1 | 62735.57 | 6.30 | 23.73 | 72.61 | −0.541 | 66 | 63 |
AHB33631.1 | 62552.79 | 5.60 | 26.59 | 75.85 | −0.456 | 71 | 60 |
AHW46443.1 | 57361.16 | 5.16 | 26.56 | 66.57 | −0.419 | 56 | 38 |
AOA60285.1 | 40643.19 | 5.59 | 44.78 | 84.28 | −0.515 | 54 | 45 |
AOA60286.1 | 40450.78 | 5.25 | 44.09 | 82.21 | −0.428 | 54 | 41 |
AOA60287.1 | 57844.96 | 4.68 | 33.97 | 82.37 | −0.371 | 79 | 48 |
CelGH5 (this study) | 37656.79 | 6.72 | 41.17 | 77.72 | −0.303 | 39 | 38 |